<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>perinucleolar compartment &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/perinucleolar-compartment/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Sun, 04 Oct 2026 13:35:40 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1.2</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>perinucleolar compartment &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Metarrestin&#8217;s Anti-Cancer Mechanism Mapped Through Network Pharmacology</title>
		<link>https://bioengineer.org/metarrestins-anti-cancer-mechanism-mapped-through-network-pharmacology/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Sun, 04 Oct 2026 13:35:40 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[BMC Cancer]]></category>
		<category><![CDATA[CDKN1B]]></category>
		<category><![CDATA[cell cycle]]></category>
		<category><![CDATA[metarrestin]]></category>
		<category><![CDATA[metastatic cancer]]></category>
		<category><![CDATA[ML246]]></category>
		<category><![CDATA[molecular docking]]></category>
		<category><![CDATA[molecular dynamics]]></category>
		<category><![CDATA[network pharmacology]]></category>
		<category><![CDATA[Pan-cancer analysis]]></category>
		<category><![CDATA[perinucleolar compartment]]></category>
		<category><![CDATA[protein-protein interaction]]></category>
		<guid isPermaLink="false">https://bioengineer.org/?p=401077</guid>

					<description><![CDATA[A new network pharmacology study maps how the anti-metastatic drug metarrestin rewires cancer cell protein networks and identifies the cell-cycle regulator CDKN1B as its highest-affinity target.]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">401077</post-id>	</item>
	</channel>
</rss>
